重庆西山科技股份有限公司 关于收到北京仲裁委员会撤案决定暨公司涉及仲裁事项的进展公告

Core Viewpoint - The arbitration cases involving Chongqing Xishan Technology Co., Ltd. have been withdrawn, and this decision will not significantly impact the company's daily operations or profits [1][6]. Group 1: Arbitration Case Overview - The company was involved in arbitration initiated by China National Pharmaceutical Group United Medical Devices Co., Ltd. and China National Pharmaceutical Group Beijing United Meidi Medical Devices Co., Ltd. [2] - The arbitration claims amounted to approximately 35.71 million yuan, but the specific compensation obligations and amounts remain unclear [1][2]. Group 2: Arbitration Progress - The Beijing Arbitration Commission accepted the arbitration case on August 29, 2025, under the case number (2025) Jingzhong Anzi No. 07963 [3]. - The arbitration tribunal decided to withdraw the case on January 9, 2026, following the applicant's request to withdraw all arbitration claims [4]. Group 3: Financial Implications - The arbitration fees for the first case totaled 107,956.39 yuan, with the remaining fees refunded to the applicant [4]. - The arbitration fees for the second case amounted to 83,575.2 yuan, with the remaining fees also refunded [6].